$AXON
AXON ENTERPRISE, INC.

2021 Q4 Form 10-Q Financial Statement

#000155837021016019 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $217.6M $232.0M $218.8M
YoY Change -3.77% 39.38% 54.89%
Cost Of Revenue $82.52M $87.42M $80.87M
YoY Change -2.69% 28.18% 52.34%
Gross Profit $135.1M $144.6M $137.9M
YoY Change -4.42% 47.16% 56.42%
Gross Profit Margin 62.07% 62.32% 63.04%
Selling, General & Admin $111.5M $99.30M $177.7M
YoY Change 14.31% 33.38% 145.75%
% of Gross Profit 82.52% 68.68% 128.81%
Research & Development $50.67M $42.38M $53.95M
YoY Change 33.35% 44.92% 82.52%
% of Gross Profit 37.52% 29.32% 39.12%
Depreciation & Amortization $5.274M $4.838M $4.292M
YoY Change 48.98% 54.57% 46.48%
% of Gross Profit 3.9% 3.35% 3.11%
Operating Expenses $162.1M $141.7M $231.6M
YoY Change 19.56% 36.64% 127.4%
Operating Profit -$27.07M $2.890M -$93.69M
YoY Change -574.84% -153.04% 585.03%
Interest Expense -$10.15M -$5.530M $41.84M
YoY Change -407.52% -371.08% 2493.99%
% of Operating Profit -191.35%
Other Income/Expense, Net
YoY Change
Pretax Income -$37.21M -$2.640M -$51.84M
YoY Change -513.49% -22.56% 329.78%
Income Tax -$23.71M -$51.16M -$4.727M
% Of Pretax Income
Net Earnings -$13.51M $48.52M -$47.12M
YoY Change -152.36% -5658.3% 53.18%
Net Earnings / Revenue -6.21% 20.92% -21.53%
Basic Earnings Per Share $0.73 -$0.72
Diluted Earnings Per Share -$194.8K $0.67 -$0.72
COMMON SHARES
Basic Shares Outstanding 68.47M 66.19M 65.17M
Diluted Shares Outstanding 72.44M 65.17M

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $428.5M $365.0M $655.3M
YoY Change -23.75% -27.99% 17.6%
Cash & Equivalents $356.3M $281.7M $266.4M
Short-Term Investments $72.18M $83.34M $388.9M
Other Short-Term Assets $56.54M $52.71M $45.46M
YoY Change 53.22% 48.9% 7.21%
Inventory $108.7M $93.28M $91.74M
Prepaid Expenses
Receivables $501.2M $396.2M $288.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.109B $1.124B $1.081B
YoY Change 12.99% 28.31% 22.04%
LONG-TERM ASSETS
Property, Plant & Equipment $138.5M $128.8M $119.9M
YoY Change 31.25% 25.4% 164.25%
Goodwill $43.59M $25.57M $25.18M
YoY Change 72.95% 2.23% 1.1%
Intangibles $15.47M $7.426M $7.870M
YoY Change 63.74% -27.62% -29.39%
Long-Term Investments $114.8M $108.0M $107.2M
YoY Change 12.06% -15.6% -21.7%
Other Assets $98.25M $91.63M $84.24M
YoY Change 44.04% 36.17% 32.03%
Total Long-Term Assets $578.7M $521.6M $446.0M
YoY Change 45.02% 29.33% 28.45%
TOTAL ASSETS
Total Short-Term Assets $1.109B $1.124B $1.081B
Total Long-Term Assets $578.7M $521.6M $446.0M
Total Assets $1.688B $1.645B $1.527B
YoY Change 22.24% 28.63% 23.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.22M $27.42M $7.778M
YoY Change 33.46% 22.18% -80.61%
Accrued Expenses $103.7M $88.89M $66.91M
YoY Change 73.3% 19.94% 3.79%
Deferred Revenue $265.6M $250.7M $186.9M
YoY Change 61.99% 61.99% 44.31%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $418.5M $379.9M $272.9M
YoY Change 63.27% 46.93% 12.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.392M $29.84M $32.36M
YoY Change -80.27% 4.37% 14.6%
Total Long-Term Liabilities $5.392M $29.84M $32.36M
YoY Change -80.27% 4.37% 14.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $418.5M $379.9M $272.9M
Total Long-Term Liabilities $5.392M $29.84M $32.36M
Total Liabilities $640.4M $531.5M $429.2M
YoY Change 58.2% 38.41% 18.2%
SHAREHOLDERS EQUITY
Retained Earnings $109.9M $123.4M $74.87M
YoY Change -35.33% -14.35% -48.35%
Common Stock $1.095B $1.147B $1.179B
YoY Change 13.83% 26.29% 33.43%
Preferred Stock
YoY Change
Treasury Stock (at cost) $155.9M $155.9M $155.9M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $20.22M $20.22M $20.22M
Shareholders Equity $1.048B $1.114B $1.098B
YoY Change
Total Liabilities & Shareholders Equity $1.688B $1.645B $1.527B
YoY Change 22.24% 28.63% 23.84%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income -$13.51M $48.52M -$47.12M
YoY Change -152.36% -5658.3% 53.18%
Depreciation, Depletion And Amortization $5.274M $4.838M $4.292M
YoY Change 48.98% 54.57% 46.48%
Cash From Operating Activities $12.93M $16.45M $34.18M
YoY Change -62.33% 47.66% -267.52%
INVESTING ACTIVITIES
Capital Expenditures -$13.62M -$12.48M -$13.61M
YoY Change 104.2% -78.67% 151.65%
Acquisitions
YoY Change
Other Investing Activities $172.8M $79.45M $94.18M
YoY Change -448.53% -183.16% -179.32%
Cash From Investing Activities $159.1M $66.97M $80.57M
YoY Change -382.97% -143.46% -164.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -97.28M -66.59M -3.262M
YoY Change 10473.8% 5845.54% -101.06%
NET CHANGE
Cash From Operating Activities 12.93M 16.45M 34.18M
Cash From Investing Activities 159.1M 66.97M 80.57M
Cash From Financing Activities -97.28M -66.59M -3.262M
Net Change In Cash 74.79M 16.83M 111.5M
YoY Change -427.47% -111.68% -31.16%
FREE CASH FLOW
Cash From Operating Activities $12.93M $16.45M $34.18M
Capital Expenditures -$13.62M -$12.48M -$13.61M
Free Cash Flow $26.55M $28.93M $47.79M
YoY Change -35.23% -58.48% -418.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Central Index Key
EntityCentralIndexKey
0001069183
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67577868
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63766555
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16391
dei Entity Registrant Name
EntityRegistrantName
Axon Enterprise, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0741227
dei Entity Address Address Line1
EntityAddressAddressLine1
17800 North 85th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
dei City Area Code
CityAreaCode
480
dei Local Phone Number
LocalPhoneNumber
991-0797
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 Par Value
dei Trading Symbol
TradingSymbol
AXON
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68467571
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
281691000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155440000
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
83340000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
216557000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
406525000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2425000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2105000
CY2021Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
265267000
CY2020Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
229201000
CY2021Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
130976000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
63945000
CY2021Q3 us-gaap Inventory Net
InventoryNet
93279000
CY2020Q4 us-gaap Inventory Net
InventoryNet
89958000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52710000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36883000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1123820000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
981952000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
128808000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105494000
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
104169000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
45770000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7426000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9448000
CY2021Q3 us-gaap Goodwill
Goodwill
25571000
CY2020Q4 us-gaap Goodwill
Goodwill
25205000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
49431000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
90681000
CY2021Q3 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
12621000
CY2020Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
22457000
CY2021Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
43394000
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
20099000
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
58520000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
11711000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91627000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68206000
CY2021Q3 us-gaap Assets
Assets
1645387000
CY2020Q4 us-gaap Assets
Assets
1381023000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
27418000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24142000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88894000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59843000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
250651000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
163959000
CY2021Q3 axon Customer Deposit Current
CustomerDepositCurrent
6118000
CY2020Q4 axon Customer Deposit Current
CustomerDepositCurrent
2956000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6809000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5431000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
379890000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
256331000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111892000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111222000
CY2021Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4580000
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4503000
CY2021Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5125000
CY2020Q4 us-gaap Liabilities
Liabilities
404768000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67577868
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63766555
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645803000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
454863000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87422000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
68202000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
239954000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
179838000
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4732000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
155000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
649000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29842000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27331000
CY2021Q3 us-gaap Liabilities
Liabilities
531484000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1147478000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
962159000
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
20220227
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20220227
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
123391000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
169901000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1020000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
141000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1113903000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
976255000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1645387000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1381023000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231989000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166442000
CY2021Q3 us-gaap Gross Profit
GrossProfit
144567000
CY2020Q3 us-gaap Gross Profit
GrossProfit
98240000
us-gaap Gross Profit
GrossProfit
405849000
us-gaap Gross Profit
GrossProfit
275025000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
99295000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74443000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
403554000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
209763000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42382000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29246000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143352000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
85187000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
141677000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
103689000
us-gaap Operating Expenses
OperatingExpenses
546906000
us-gaap Operating Expenses
OperatingExpenses
294950000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2890000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5449000
us-gaap Operating Income Loss
OperatingIncomeLoss
-141057000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19925000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5530000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2040000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
36896000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4594000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2640000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3409000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-104161000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15331000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-51164000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2536000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-57651000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12227000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
48524000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-873000
us-gaap Net Income Loss
NetIncomeLoss
-46510000
us-gaap Net Income Loss
NetIncomeLoss
-27558000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66192000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63496000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65139000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61159000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72441000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63496000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65139000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61159000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
48524000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-873000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
559590000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
306779000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-310000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33835000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-30759000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
678000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
869813000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-1119000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26094000
us-gaap Net Income Loss
NetIncomeLoss
-46510000
us-gaap Net Income Loss
NetIncomeLoss
-27558000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-793000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1238000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1161000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-456000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47731000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
365000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47671000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28014000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
976255000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-7045000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89610000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-47917000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1010904000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-3268000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
137549000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47117000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-369000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1097699000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
105615000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-172204000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35062000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
48524000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-793000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1113903000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
543495000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-5162000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20195000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4074000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2372000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-873000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1238000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
895153000
us-gaap Profit Loss
ProfitLoss
-46510000
us-gaap Profit Loss
ProfitLoss
-27558000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13420000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8944000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-130000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-252000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-74000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1429000
us-gaap Gain Loss On Investments
GainLossOnInvestments
34195000
us-gaap Share Based Compensation
ShareBasedCompensation
262221000
us-gaap Share Based Compensation
ShareBasedCompensation
80124000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-58893000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11670000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
77000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
573000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4606000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1830000
us-gaap Operating Lease Cost
OperatingLeaseCost
4087000
us-gaap Operating Lease Cost
OperatingLeaseCost
2743000
axon Credit Loss Reserve
CreditLossReserve
615000
axon Credit Loss Reserve
CreditLossReserve
776000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
118094000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
48551000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3154000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
59371000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
28906000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
4822000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28528000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25365000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
87558000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
34099000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111564000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4163000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
362479000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
516687000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
499172000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
287199000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
14546000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36501000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66023000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
31000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
94000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
157000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
177000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
20500000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
4700000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
700000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
93412000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-300294000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
105615000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
306779000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
295000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
182517000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6886000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-76902000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
300188000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1827000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-303000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
126247000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3754000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155551000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
172355000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
281798000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176109000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
281691000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
176000000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
107000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
109000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
281798000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176109000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5016000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7678000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1211000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1734000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1476000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
582000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
539000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1176000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-192000
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1363000
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
745000
CY2021Q3 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
5000000.0
axon Investments In Number Of Affiliates
InvestmentsInNumberOfAffiliates
3
CY2020Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4700000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
48524000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-873000
us-gaap Net Income Loss
NetIncomeLoss
-46510000
us-gaap Net Income Loss
NetIncomeLoss
-27558000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66192000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63496000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65139000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61159000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6249000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72441000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63496000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65139000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61159000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3481000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12793000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8920000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12904000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
axon Warranty Period After Purchase Of Product
WarrantyPeriodAfterPurchaseOfProduct
P1Y
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
769000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231989000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166442000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645803000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
454863000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231989000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166442000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645803000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
454863000
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
174370000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
362543000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
145012000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
250651000
us-gaap Reclassifications
Reclassifications
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification of Prior Year Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are not material and had no effect on the reported results of operations.</p>
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111892000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
362543000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
163959000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111222000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
275181000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
250651000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111892000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
362543000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
163959000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111222000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
275181000
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2390000000
CY2021Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
637778000
CY2021Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
129000
CY2021Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
6777000
CY2021Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
631130000
CY2021Q3 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
281703000
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
83340000
CY2021Q3 axon Short Term Investment
ShortTermInvestment
216628000
CY2021Q3 axon Long Term Investment
LongTermInvestment
49447000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
281691000
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
83340000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
216557000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
49431000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6700000
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6700000
CY2021Q3 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
100000
CY2020Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
-200000
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
652816000
CY2020Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
401000
CY2020Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
128000
CY2020Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
653089000
CY2020Q4 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
155443000
CY2020Q4 axon Short Term Investment
ShortTermInvestment
406667000
CY2020Q4 axon Long Term Investment
LongTermInvestment
90706000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155440000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
406525000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
90681000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3376000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
698000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
54000
axon Allowance For Doubtful Accounts Receivable Other
AllowanceForDoubtfulAccountsReceivableOther
73000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4093000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2425000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2105000
CY2021Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1409000
CY2020Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
794000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
259000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
477000
CY2021Q3 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
4093000
CY2020Q4 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3376000
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
33951000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
39194000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
59328000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
50764000
CY2021Q3 us-gaap Inventory Net
InventoryNet
93279000
CY2020Q4 us-gaap Inventory Net
InventoryNet
89958000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
183618000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
152679000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
54810000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47185000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
128808000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105494000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
11711000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
20500000
axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
40855000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
58520000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
30156000
axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
42910000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
58520000
axon Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities
12300000
CY2021Q3 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4996000
CY2020Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4654000
CY2021Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
45663000
CY2020Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
32455000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
58000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
62000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24732000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22308000
CY2021Q3 axon Deferred Implementation Costs
DeferredImplementationCosts
4132000
CY2021Q3 axon Prepaid Expenses Deposits And Other Assets Noncurrent
PrepaidExpensesDepositsAndOtherAssetsNoncurrent
12046000
CY2020Q4 axon Prepaid Expenses Deposits And Other Assets Noncurrent
PrepaidExpensesDepositsAndOtherAssetsNoncurrent
8727000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91627000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68206000
CY2021Q3 axon Deferred Implementation Costs Assets Placed Into Service
DeferredImplementationCostsAssetsPlacedIntoService
4300000
CY2021Q3 axon Government Grant Assets
GovernmentGrantAssets
900000
CY2021Q3 axon Deferred Government Grant Assets
DeferredGovernmentGrantAssets
100000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
59559000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36892000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5282000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3055000
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1363000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
769000
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
4459000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3848000
CY2021Q3 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
6316000
CY2020Q4 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
4597000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11915000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10682000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88894000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59843000
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
104000000.0
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11400000
us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
7100000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.553
us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.118
CY2018Q2 axon Market Capitalization Goal For Tranche First Tranche
MarketCapitalizationGoalForTrancheFirstTranche
2500000000
CY2018Q2 axon Market Capitalization Goal For Tranche Incremental Increase
MarketCapitalizationGoalForTrancheIncrementalIncrease
1000000000.0
CY2021Q3 axon Revenue Goal Goal Number One
RevenueGoalGoalNumberOne
710058000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Nine
AdjustedEBITDAGoalGoalNumberNine
125000000
CY2021Q3 axon Revenue Goal Goal Number Two
RevenueGoalGoalNumberTwo
860058000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Ten
AdjustedEBITDAGoalGoalNumberTen
155000000
CY2021Q3 axon Revenue Goal Goal Number Three
RevenueGoalGoalNumberThree
1010058000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Eleven
AdjustedEBITDAGoalGoalNumberEleven
175000000
CY2021Q3 axon Revenue Goal Goal Number Four
RevenueGoalGoalNumberFour
1210058000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Twelve
AdjustedEBITDAGoalGoalNumberTwelve
190000000
CY2021Q3 axon Revenue Goal Goal Number Five
RevenueGoalGoalNumberFive
1410058000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Thirteen
AdjustedEBITDAGoalGoalNumberThirteen
200000000
CY2021Q3 axon Revenue Goal Goal Number Six
RevenueGoalGoalNumberSix
1610058000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Fourteen
AdjustedEBITDAGoalGoalNumberFourteen
210000000
CY2021Q3 axon Revenue Goal Goal Number Seven
RevenueGoalGoalNumberSeven
1810058000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Fifteen
AdjustedEBITDAGoalGoalNumberFifteen
220000000
CY2021Q3 axon Revenue Goal Goal Number Eight
RevenueGoalGoalNumberEight
2010058000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Sixteen
AdjustedEBITDAGoalGoalNumberSixteen
230000000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Sixteen
AdjustedEBITDAGoalGoalNumberSixteen
230000000
CY2021Q3 axon Revenue Goal Goal Number Two
RevenueGoalGoalNumberTwo
860100000
CY2021Q3 axon Revenue Goal Goal Number Three
RevenueGoalGoalNumberThree
1010100000
CY2021Q3 axon Revenue Goal Goal Number Four
RevenueGoalGoalNumberFour
1210100000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Nine
AdjustedEBITDAGoalGoalNumberNine
125000000.0
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Ten
AdjustedEBITDAGoalGoalNumberTen
155000000.0
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Eleven
AdjustedEBITDAGoalGoalNumberEleven
175000000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Twelve
AdjustedEBITDAGoalGoalNumberTwelve
190000000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Thirteen
AdjustedEBITDAGoalGoalNumberThirteen
200000000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Fourteen
AdjustedEBITDAGoalGoalNumberFourteen
210000000
CY2021Q3 axon Adjusted Ebitda Goal Goal Number Fifteen
AdjustedEBITDAGoalGoalNumberFifteen
220000000
CY2021Q3 axon Revenue Goal Goal Number One
RevenueGoalGoalNumberOne
710100000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
219500000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1600000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
35062000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
26094000
us-gaap Share Based Compensation
ShareBasedCompensation
262221000
us-gaap Share Based Compensation
ShareBasedCompensation
80124000
us-gaap Gross Profit
GrossProfit
275025000
CY2021Q3 axon Maximum Ratio Of Liabilities To Tangible Net Worth
MaximumRatioOfLiabilitiesToTangibleNetWorth
2.50
CY2021Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2
CY2021Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
5000000.0
axon Employee Deferrals Vested Percentage
EmployeeDeferralsVestedPercentage
1
CY2021Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000
CY2020Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1300000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5600000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4100000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231989000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
166442000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87422000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
68202000
CY2021Q3 us-gaap Gross Profit
GrossProfit
144567000
CY2020Q3 us-gaap Gross Profit
GrossProfit
98240000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42382000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29246000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645803000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
454863000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
239954000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
179838000
us-gaap Gross Profit
GrossProfit
405849000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143352000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
85187000

Files In Submission

Name View Source Status
0001558370-21-016019-index-headers.html Edgar Link pending
0001558370-21-016019-index.html Edgar Link pending
0001558370-21-016019.txt Edgar Link pending
0001558370-21-016019-xbrl.zip Edgar Link pending
axon-20210930.xsd Edgar Link pending
axon-20210930x10q.htm Edgar Link pending
axon-20210930x10q_htm.xml Edgar Link completed
axon-20210930xex10d1.htm Edgar Link pending
axon-20210930xex31d1.htm Edgar Link pending
axon-20210930xex31d2.htm Edgar Link pending
axon-20210930xex32.htm Edgar Link pending
axon-20210930_cal.xml Edgar Link unprocessable
axon-20210930_def.xml Edgar Link unprocessable
axon-20210930_lab.xml Edgar Link unprocessable
axon-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending